tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geulah Livshits, 203 are a BUY (97.13%), 6 are a HOLD (2.87%).
Analyst Geulah Livshits, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 29.75% that have a potential upside of 39.98% achieved within 123 days.
Geulah Livshits’s has documented 367 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TSHA, Taysha Gene Therapies at 06-Jan-2026.
Analyst best performing recommendations are on RCKT (ROCKET PHARMACEUTICALS).
The best stock recommendation documented was for RCKT (ROCKET PHARMACEUTICALS) at 12/8/2020. The price target of $46 was fulfilled within 1 day with a profit of $13.97 (43.62%) receiving and performance score of 436.15.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 13-May-2022
$80
$26.16 (48.59%)
$80
19 days ago
(23-Dec-2025)
8/26 (30.77%)
$22.09 (38.15%)
214
Buy
Since 12-Nov-2019
$86
$32.16 (59.73%)
$86
19 days ago
(23-Dec-2025)
12/19 (63.16%)
$28.09 (48.51%)
161
Buy
Since 28-Oct-2019
$74
$20.16 (37.44%)
$82
1 months 16 days ago
(26-Nov-2025)
3/16 (18.75%)
$20.7 (38.84%)
27
Buy
Since 18-Aug-2023
$77
$23.16 (43.02%)
$82
1 months 30 days ago
(12-Nov-2025)
11/20 (55%)
$21.79 (39.47%)
196
Hold
Since 16-Feb-2022
$50
$-3.84 (-7.13%)
$42
1 months 30 days ago
(12-Nov-2025)
13/16 (81.25%)
$-5.21 (-9.44%)
152
Which stock is Geulah Livshits is most bullish on?
Which stock is Geulah Livshits is most reserved on?
What Year was the first public recommendation made by Geulah Livshits?
